Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levo-Carnitine for Vasopressor Dependent Septic Shock
NCT01665092Phase 2Completed
- Sponsor
- University of Mississippi Medical Center
- Start
- Jan 2013
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of levocarnitine in septic shock, sponsored by University of Mississippi Medical Center. Started Jan 2013; status: completed.
02
Drugs
levocarnitine
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT01665092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01665092.